Get started
AIM IMMUNOTECH INC COM USD0.001AIM IMMUNOTECH INC COM USD0.001AIM IMMUNOTECH INC COM USD0.001

AIM IMMUNOTECH INC COM USD0.001

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

0A4Y chart


Full chart

0A4Y upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪14.21 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.472 USD
Net income (FY)
‪−28.96 M‬ USD
Revenue (FY)
‪202.00 K‬ USD
Shares float
‪58.21 M‬
Beta (1Y)
1.17

Employees


Employees (FY)
26
Change (1Y)
+2 +8.33%
Revenue / Employee (1Y)
‪7.77 K‬ USD
Net income / Employee (1Y)
‪−1.11 M‬ USD

About AIM ImmunoTech Inc.


Sector
Health Technology
CEO
Thomas Kenwood Equels
Headquarters
Ocala
Website
aimimmuno.com
Founded
1966
FIGI
BBG00XCCRNP0
AIM ImmunoTech, Inc. is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Its products include Alferon N Injection and Ampligen. The Alferon N Injection is a purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon. The Ampligen is used in the treatment of chronic fatigue syndrome and as a vaccine enhancer for therapeutic and/or preventative development related to influenza and cancer treatments. The company was founded in August 1966 and is headquartered in Ocala, FL.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

0A4Y news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 0A4Y is 0.230 USD — it has decreased by −2.75% in the past 24 hours. Watch AIM IMMUNOTECH INC COM USD0.001 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange AIM IMMUNOTECH INC COM USD0.001 stocks are traded under the ticker 0A4Y.
0A4Y stock has fallen by −5.93% compared to the previous week, the month change is a −11.45% fall, over the last year AIM IMMUNOTECH INC COM USD0.001 has showed a −51.32% decrease.
We've gathered analysts' opinions on AIM IMMUNOTECH INC COM USD0.001 future price: according to them, 0A4Y price has a max estimate of 5.00 USD and a min estimate of 1.00 USD. Watch 0A4Y chart and read a more detailed AIM IMMUNOTECH INC COM USD0.001 stock forecast: see what analysts think of AIM IMMUNOTECH INC COM USD0.001 and suggest that you do with its stocks.
0A4Y reached its all-time high on Feb 10, 2021 with the price of 3.040 USD, and its all-time low was 0.234 USD and was reached on Nov 15, 2024. View more price dynamics on 0A4Y chart.
See other stocks reaching their highest and lowest prices.
0A4Y stock is 2.83% volatile and has beta coefficient of 1.17. Track AIM IMMUNOTECH INC COM USD0.001 stock price on the chart and check out the list of the most volatile stocks — is AIM IMMUNOTECH INC COM USD0.001 there?
Today AIM IMMUNOTECH INC COM USD0.001 has the market capitalization of ‪14.68 M‬, it has decreased by −3.92% over the last week.
Yes, you can track AIM IMMUNOTECH INC COM USD0.001 financials in yearly and quarterly reports right on TradingView.
AIM IMMUNOTECH INC COM USD0.001 is going to release the next earnings report on Apr 7, 2025. Keep track of upcoming events with our Earnings Calendar.
0A4Y earnings for the last quarter are −0.06 USD per share, whereas the estimation was −0.09 USD resulting in a 30.77% surprise. The estimated earnings for the next quarter are −0.10 USD per share. See more details about AIM IMMUNOTECH INC COM USD0.001 earnings.
AIM IMMUNOTECH INC COM USD0.001 revenue for the last quarter amounts to ‪17.50 K‬ USD, despite the estimated figure of ‪17.50 K‬ USD. In the next quarter, revenue is expected to reach ‪67.50 K‬ USD.
0A4Y net income for the last quarter is ‪−3.70 M‬ USD, while the quarter before that showed ‪−1.84 M‬ USD of net income which accounts for −101.53% change. Track more AIM IMMUNOTECH INC COM USD0.001 financial stats to get the full picture.
No, 0A4Y doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 19, 2024, the company has 26.00 employees. See our rating of the largest employees — is AIM IMMUNOTECH INC COM USD0.001 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AIM IMMUNOTECH INC COM USD0.001 EBITDA is ‪−27.67 M‬ USD, and current EBITDA margin is ‪−15.68 K‬%. See more stats in AIM IMMUNOTECH INC COM USD0.001 financial statements.
Like other stocks, 0A4Y shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AIM IMMUNOTECH INC COM USD0.001 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AIM IMMUNOTECH INC COM USD0.001 technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AIM IMMUNOTECH INC COM USD0.001 stock shows the sell signal. See more of AIM IMMUNOTECH INC COM USD0.001 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.